Excimer Laser Trabeculostomy for Glaucoma
(ELTGTS Trial)

Recruiting in Palo Alto (17 mi)

+20 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: ELT Sight, Inc

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?This trial evaluates the safety and effectiveness of the ELIOS System, a procedure to lower eye pressure, in adults with mild to moderate primary open-angle glaucoma who are undergoing cataract surgery.

Eligibility Criteria

Adults over 45 with mild to moderate primary open-angle glaucoma and cataracts can join this trial. They must have specific intraocular pressure levels, a certain angle in their eye's drainage area, and no past major eye surgeries. Pregnant or nursing women and those not using birth control are excluded.

Inclusion Criteria

My eye pressure is 24 mmHg or less with medication.

CD ratio <=0.8

Unmedicated diurnal IOP of >=22 mmHg and <=34 mmHg

+4 more

Exclusion Criteria

I have been diagnosed with a condition that is causing my vision to worsen over time.

Non-study eye with BCVA worse than 20/80

Known corticosteroid responder

+4 more

Participant Groups

The ELIOS System procedure is being tested for its ability to lower the pressure inside the eye when combined with cataract surgery in adults with open-angle glaucoma. The study aims to assess both safety and effectiveness of this treatment.

1Treatment groups

Experimental Treatment

Group I: ELIOS ProcedureExperimental Treatment1 Intervention

ELIOS Procedure

ELIOS Procedure is already approved in European Union for the following indications:

🇪🇺 Approved in European Union as ELIOS Procedure for: